These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4891919)

  • 1. Ganglioside as a prophylactic agent in experimental tetanus in mice.
    Mellanby J; Mellanby H; Pope D; Van Heyningen WE
    J Gen Microbiol; 1968 Dec; 54(2):161-8. PubMed ID: 4891919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoenzimatic detection of the Clostridium tetani bacterial toxin: an alternative to mice bioassays].
    Chaves F; León G; Hernández-Chavarría F
    Rev Biol Trop; 2006 Jun; 54(2):253-6. PubMed ID: 18494295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies in experimental tetanus infection.
    Smith JW; MacIver AG
    J Med Microbiol; 1969 Nov; 2(4):385-93. PubMed ID: 4929794
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth and toxin production of Tetanus bacilli in vivo.
    Smith JW; MacIver AG
    J Med Microbiol; 1974 Nov; 7(4):497-504. PubMed ID: 4615153
    [No Abstract]   [Full Text] [Related]  

  • 5. Current concepts in the management of Clostridium tetani infection.
    Brook I
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):327-36. PubMed ID: 18588497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic tests: Clostridium tetani].
    Takahashi M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():206-9. PubMed ID: 16111228
    [No Abstract]   [Full Text] [Related]  

  • 7. [The preventive properties and therapeutic efficacy of an antitetanus immunoglobulin for experimental intravenous administration].
    Sapozhnikova VS; Dumkin IM
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):81-4. PubMed ID: 7992546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic effect of ornidazole on experimental tetanus in mice.
    Erenmemisoglu A; Tekol Y; Aydin N
    Drugs Exp Clin Res; 1995; 21(2):59-63. PubMed ID: 7555610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A contribution on the active and passive vaccination against Clostridium novyi and Clostridium tetani].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):350-6. PubMed ID: 4233547
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.
    Luo P; Qin L; Mao X; Chen L; Yu S; Li Q; Liu W; Zhang W; Gu J; Zou Q
    Vaccine; 2012 Oct; 30(45):6449-55. PubMed ID: 22889825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
    Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
    Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against diphtheria and tetanus. Assays, antigens, adjuvants and application.
    Aggerbeck H
    APMIS Suppl; 1998; 81():1-40. PubMed ID: 9810281
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of the treatment of crude tetanus toxin with ganglioside cerebroside complex on sphincter paralysis in the rabbit's eye.
    Mellanby J; Pope D; Ambache N
    J Gen Microbiol; 1968 Mar; 50(3):479-86. PubMed ID: 5652077
    [No Abstract]   [Full Text] [Related]  

  • 14. THE PROTECTIVE EFFECT OF ALDOSTERONE AGAINST THE TOXIN OF CLOSTRIDIUM TETANI.
    KOSTRUBIAK W; HOWARD JM
    Surg Gynecol Obstet; 1965 Jul; 121():59-62. PubMed ID: 14314102
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical effects of tetanus toxin on model membranes containing ganglioside.
    Clowes AW; Cherry RJ; Chapman D
    J Mol Biol; 1972 Jun; 67(1):49-57. PubMed ID: 5065000
    [No Abstract]   [Full Text] [Related]  

  • 16. [The present state of prevention and treatment of tetanus].
    Manz R; Drost R
    Anaesthesist; 1969 Apr; 18(4):101-8. PubMed ID: 4902763
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of antibody Fab fragments specifically directed to two different complementary parts of the tetanus toxin molecule for studying the mode of action of the toxin.
    Gawade S; Bon C; Bizzini B
    Brain Res; 1985 May; 334(1):139-46. PubMed ID: 3995306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Density and distribution of Clostridium tetani in the soil.
    Ebisawa I; Takayanagi M; Kurata M; Kigawa M
    Jpn J Exp Med; 1986 Apr; 56(2):69-74. PubMed ID: 3525907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study on intradermal antitetanus antityphoid immunization.
    Dimache G; Stoean C; Durbacă S; Laşcu N; Croitoru M; Dimache A
    Roum Arch Microbiol Immunol; 1992; 51(1-2):53-65. PubMed ID: 1457823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a new equine tetanus immunoglobulin associated with tetanus-diphtheria vaccine.
    Lang J; Kamga-Fotso L; Peyrieux JC; Blondeau C; Lutsch C; Forrat R
    Am J Trop Med Hyg; 2000; 63(5-6):298-305. PubMed ID: 11421382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.